Abstract:Objectives: Trace amines are powerful neuromodulators influencing the release and reuptake of catecholamines. These low concentrated endogenous amines impact mood, cognition, and hormone regulation. Dysregulation of trace amines have been associated with a variety of diseases, such as schizophrenia, Parkinson's disease, migraine, depression and more. Succesfull simultaneous quantification of trace amines, their precursors and metabolites would benefit both research and patient care. Since these compounds have various functional groups and are present in biological matrices with large concentration difference, their simultaneous quantification is an analytical challenge. Our goal was to develop a highly sensitive LC-MS/MS assay to simultaneously quantify trace amines, their precursors and metabolites in plasma. Methods: Our method is based on a simple two-step in-matrix derivatization protocol: propionic anhydride (PA) and 3-Ethyl-1-[3-(dimethylamino)propyl]carbodiimide (EDC) in combination with 2,2,2-trifluoroethylamine (TFEA) followed by online solid phase extraction combined with LC-MS/MS. Fifteen metabolites can be measured simultaneously, three precursors, eight trace amines and four metabolites. Validation of this method was performed according to international validation guidelines. The pre-analytical stability of trace amines was assessed. Results: This novel method was successful in quantifying trace amines, their precursors, and metabolites in plasma. Using just 50 µl human plasma, we were able to accomplish limit of quantification for 2-phenylethylamine and N-methyl-phenylethylamine of 0.2 nmol/L and 0.1 nmol/L for tyramine and n-methyltyramine. Inter-and intra-assay imprecision was < 15 % for all analytes. Stability assessment showed susceptibility of certain trace amines e.g. 2-phenylethylamine and N-methyl-phenylethylamine to enzymatic degradation in plasma. The addition of the monoamine oxidase inhibitor pargyline to plasma prevented this enzymatic degradation. Conclusions: We developed a novel LC-MS/MS method that1) uses a new double derivatization technique, 2) is automated with online SPE, 3) uses far less sample volume then previous methods and 4) detects more components in the same sample (eight trace amines, three precursors, and four metabolites) with high specificity and selectivity. Furthermore, addition of MAO A/B inhibitor prevents degradation and guarantees more accurate quantification of trace amines.

Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue

On-Tissue Chemical Derivatization for Comprehensive Mapping of Brain Carboxyl and Aldehyde Metabolites by MALDI–MS Imaging

Bromopyrylium derivatization facilitates identification by mass spectrometry imaging of monoamine neurotransmitters and small molecule neuroactive compounds.

Visualizing Neurotransmitters and Metabolites in the Central Nervous System by High Resolution and High Accuracy Mass Spectrometric Imaging

Optimizing neurotransmitter pathway detection by IR-MALDESI-MSI in mouse brain

Simultaneous Mapping of Amino Neurotransmitters and Nucleoside Neuromodulators on Brain Tissue Sections by On-Tissue Chemoselective Derivatization and MALDI-MSI

Photocatalytic Reactive Liquid Microjunction Surface Sampling-Mass Spectrometry for Rapid and Selective In-situ Analysis of Alpha-unsubstituted Amine Metabolites or Drugs in Brain Tissue

Absolute Quantitative Analysis of Endogenous Neurotransmitters and Amino Acids by Liquid Chromatography-Tandem Mass Spectrometry Combined with Multidimensional Adsorption and Collision Energy Defect.

Mass Spectrometry Imaging Combined with Sparse Autoencoder Method Reveals Altered Phosphorylcholine Distribution in Imipramine Treated Wild-Type Mice Brains

Mass Spectrometry Imaging of Brain Cholesterol and Metabolites with Trifluoroacetic Acid-Enhanced Desorption Electrospray Ionization.

Mass spectral imaging and profiling of neuropeptides at the organ and cellular domains

Simultaneous mass spectrometric quantification of trace amines, their precursors and metabolites

Pyrylium-based derivatization for rapid labeling and enhanced detection of thiol in mass spectrometry imaging

Quantitative Analysis Of Cerebral Metabolites In Mice By In Vivo H-1-Mrs And Comparison Of Detection Results Of Tissue Extracts Obtained By H-1-Nmr And Uhpcl-Ms/Ms

Leveraging isotopologues as a general strategy to image neurotransmitters with vibrational microscopy

Toward Mass Spectrometry Imaging in the Metabolomics Scale: Increasing Metabolic Coverage Through Multiple On-Tissue Chemical Modifications

Development of an Integrated Tissue Pretreatment Protocol for Enhanced MALDI MS Imaging of Drug Distribution in the Brain

Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy

Imaging and quantification of neuropeptides in mouse pituitary tissue by atmospheric pressure matrix‐assisted laser desorption/ionization mass spectrometry

Quantitative Mass Spectrometry Imaging of Amino Acids with Isomer Differentiation in Brain Tissue Via Exhaustive Liquid Microjunction Surface Sampling–tandem Mass Tags Labeling–ultra Performance Liquid Chromatography–mass Spectrometry

LC-MS/MS-based quantification of tryptophan metabolites and neurotransmitters in the serum and brain of mice